Managers / Q1 2019 · view latest →
Lesa Sroufe & Co
CIK 0001492162 · 801 2ND AVENUE SUITE 304, SEATTLE, WA, 98104 · 206-838-8385
Summary
Lesa Sroufe & Co reported $117M in U.S.-listed holdings across 60 positions for Q1 2019.
Its largest position, Nutrien, represents 4.1% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 45.4% · $53M
- Common Stock · 44.4% · $52M
- ADR · 9.8% · $11M
- REIT · 0.2% · $278,000
- ETP · 0.1% · $124,000
- Royalty Trst · 0.1% · $66,000
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NUTRIEN LTD | NEW | +91.2K | 91.2K | +$5M | $5M |
| FEFIRSTENERGY CORP | NEW | +113.4K | 113.4K | +$5M | $5M |
| TELEFONICA BRASIL SA | NEW | +383.7K | 383.7K | +$5M | $5M |
| EXELON CORPORATION | NEW | +92.3K | 92.3K | +$5M | $5M |
| M D C HOLDING INC | NEW | +148.9K | 148.9K | +$4M | $4M |
| PAASPAN AMERICAN SILVER F | NEW | +307.6K | 307.6K | +$4M | $4M |
| ORANYORANGE SA F SPONSORED ADR 1 AD | NEW | +245.9K | 245.9K | +$4M | $4M |
| M & T BANK CORP | NEW | +24.8K | 24.8K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $147M | 69 | Apr 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $134M | 69 | Jan 22, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $124M | 69 | Oct 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $109M | 70 | Jul 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $100M | 73 | Apr 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $107M | 74 | Oct 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $103M | 71 | Jul 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $107M | 74 | May 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $98M | 65 | Feb 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $93M | 66 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $94M | 67 | Jul 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $99M | 71 | Apr 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $90M | 68 | Feb 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $83M | 65 | Oct 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $100M | 73 | Apr 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $100M | 72 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $94M | 71 | Nov 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $100M | 72 | Jul 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $90M | 68 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $84M | 69 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $72M | 64 | Oct 26, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $75M | 61 | Aug 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $74M | 58 | May 8, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2019 | $105M | 62 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $105M | 61 | Oct 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $113M | 62 | Jul 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $117M | 60 | May 3, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.